Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus

Molecular Brain Research

Volumn 130, Issue 1-2, 2004, Pages 61-67

  Zhou, Yan ^a   Spangler, Rudolph ^a   Yuferov, Vadim P ^a   Schlussmann, Stefan D ^a   Ho, Ann ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Acute "binge" cocaine; CRH; Drugs of abuse: cocaine; Hypothalamus; Neural basis of behavior; POMC; SCH23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; PREPRODYNORPHIN; PREPROENKEPHALIN; PROOPIOMELANOCORTIN; SULPIRIDE;

ADENOHYPOPHYSIS; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC SYSTEM; DRUG EFFECT; GENE EXPRESSION; HYPOPHYSIS; HYPOTHALAMUS; MALE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AMYGDALA; ANIMALS; COCAINE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HYPOTHALAMUS; MALE; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; RADIOIMMUNOASSAY; RATS; RATS, INBRED F344; RNA, MESSENGER; SULPIRIDE;

EID: 7444229345     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.07.008     Document Type: Article

References (38)

1. G. Alfredsson, C. Harnryd, and F.A. Wiesl Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients: relationship to drug concentrations Psychopharmacology 84 1984 237 241
2. B. Borowsky, and C.M. Kuhn Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation J. Pharmacol. Exp. Ther. 256 1991 204 210
3. B. Borowsky, and C.M. Kuhn D1 and D2 dopamine receptors stimulates hypothalamic-pituitary-adrenal activity in rats Neuropharmacology 31 1992 671 678
4. 3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA Brain Res. 564 1991 203 219
5. A. Branch, E.M. Unterwald, S. Lee, and M.J. Kreek Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay Mol. Brain Res. 14 1992 231 238
6. A.C. Bugnon, B. Bloch, D. Lenys, A. Gouget, and D. Felmann Comparative study of the neuronal populations containing β-endorphin, corticotropin and dopamine in the arcuate nucleus of the rat hypothalamus Neurosci. Lett. 14 1979 43 48
7. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
8. O. Civelli, N. Birnberg, and E. Herbert Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species J. Biol. Chem. 257 1982 6783 6787
9. M.J. Eaton, S. Cheung, K.E. Moore, and K.J. Lookingland Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus Brain Res. 738 1996 60 66
10. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission Proc. Natl. Acad. Sci. U. S. A. 88 1991 3772 3776
11. F.H. Gawin Cocaine addiction: psychology and neurophysiology Science 251 1991 1580 1586
12. C.R. Gerfen, T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, F.J. Monsma Jr., and D.R. Sibley D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 1990 1429 1432
13. J. Hietala, T. Seppala, J. Lappalainen, and E. Syvalahti Quantification of SCH39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood Psychopharmacology 106 1992 455 458
14. Y.L. Hurd, E.E. Brown, J.M. Finlay, H.C. Fibiger, and C.R. Gerfen Cocaine self-administration differentially alters mRNA expression of striatal peptides Mol. Brain Res. 13 1992 165 170
15. M.J. Kreek, L. Borg, Y. Zhou, and J. Schluger Relationships between endocrine functions and substance abuse syndromes: heroin and related short-acting opiates in addiction contrasted with methadone and other long-acting opioid agonists used in pharmacotherapy of addiction D. Pfaff Hormones, Brain and Behavior vol. 5 2002 Academic Press San Diego, CA 781 830 Chap. 106
16. M.J. Kreek, K.S. LaForge, and E. Butelman Pharmacotherapy of addictions Nat. Rev. 1 2002 710 726
17. S. L'Hereault, and N. Barden Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus Mol. Brain Res. 9 1991 327 332
18. Z. Liposits, and W.K. Paull Association of dopaminergic fibers with corticotropin releasing hormone (CRH)-synthesizing neurons in the paraventricular nucleus of the rat hypothalamus Histochemistry 93 1989 119 127
19. R.L. Moldow, and A.J. Fischman Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone Peptides 8 1987 819 822
20. K.E. Nikolarakis, O.F.X. Almeida, and A. Herz Feedback inhibition of opioid peptide release in the hypothalamus of the rat Neuroscience 23 1987 143 148
21. A. Nohtomi, M. Itoh, and N. Yufu Effects of sulpiride treatment on the levels of immunoreactive β-endorphin in rat hypothalamic nuclei Brain Res. 300 1984 152 156
22. C. Rivier, and W. Vale Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism Brain Res. 422 1987 403 406
23. C. Rivier, and S. Lee Stimulatory effect of cocaine on ACTH secretion: role of the hypothalamus Mol. Cell. Neurosci. 5 1994 189 195
24. S.D. Schlussman, Y. Zhang, Y. Yuferov, F.S. LaForge, A. Ho, and M.J. Kreek Acute "binge" cocaine administration elevates dynorphin mRNA in the caudate putamen of C57BL/6J but not 129/J mice Brain Res. 974 2003 249 253
25. G.W. Smith, J. Aubry, F. Dellu, A. Contarino, L.M. Bilezikjian, L.H. Gold, R. Chen, Y. Marchuk, C. Hauser, C.A. Bentley, P.E. Sawchenko, G.F. Koob, W. Vale, and K.F. Lee Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development Neuron 20 1998 1093 1102
26. R. Spangler, E.M. Unterwald, and M.J. Kreek "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen Mol. Brain Res. 19 1993 323 327
27. R. Spangler, Y. Zhou, C.E. Maggos, A. Zlobin, A. Ho, and M.J. Kreek Dopamine antagonists and "binge" cocaine effects on rat opioid and dopamine transporter mRNAs NeuroReport 7 1996 2196 2200
28. R. Spangler, Y. Zhou, S.D. Schlussman, A. Ho, and M.J. Kreek Behavioral stereotypies induced by "binge" cocaine administration are independent of drug-induced increases in corticosterone levels Behav. Brain Res. 86 1997 201 204
29. E. Tiligada, and J.F. Wilson Dopaminergic inhibition of alpha-melanocyte-stimulating hormone release from rat hypothalamus in vitro Brain Res. 457 1988 379 382
30. A.N. van den Pol, R.S. Herbst, and J.F. Powell Tyrosine hydroxylase-immunoreactive neurons of the hypothalamus: a light and electron microscopic study Neuroscience 13 1984 1117 1156
31. I. Vermes, F.J.H. Tilders, and J.C. Stoof Dopamine inhibits the release of immunoreactive β-endorphin from rat hypothalamus in vitro Brain Res. 326 1985 41 46
32. D.M. Weiner, and M.R. Brann The distribution of a dopamine D2 receptor mRNA in rat brain FEBS Lett. 253 1989 207 213
33. Y. Zhou, R. Spangler, K.S. LaForge, C.E. Maggos, A. Ho, and M.J. Kreek Corticotropin-releasing factor and CRF-R1 mRNAs in rat brain and pituitary during "binge" pattern cocaine administration and chronic withdrawal J. Pharmacol. Exp. Ther. 279 1996 351 358
34. Y. Zhou, R. Spangler, K.S. LaForge, C.E. Maggos, A. Ho, and M.J. Kreek Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA Peptides 17 1996 435 441
35. Y. Zhou, V. Yuferov, R. Spangler, C.E. Maggos, A. Ho, and M.J. Kreek Effects of memantine alone and with acute "binge" cocaine on hypothalamic-pituitary-adrenal activity in the rat Eur. J. Pharmacol. 352 1998 65 71
36. Y. Zhou, S.D. Schlussman, A. Ho, R. Spangler, A.A. Fienberg, P. Greengard, and M.J. Kreek Effects of chronic "binge" cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32 Neuroendocrinology 70 1999 196 199
37. Y. Zhou, R. Spangler, A. Ho, and M.J. Kreek Hypothalamic CRH mRNA levels are differentially modulated by repeated "binge" cocaine with or without D1 dopamine receptor blockade Mol. Brain Res. 94 2001 112 118
38. Y. Zhou, R. Spangler, V. Yuferov, S.D. Schlussman, I. Sora, A. Ho, G. Uhl, and M.J. Kreek Effects of acute "binge" cocaine on preprodynorphin or preproenkephalin mRNA levels in the caudate-putament and hypothalamic-pituitary-adrenal activity in mu opioid receptor deficient mice Synapse 45 2002 220 229